APOE and early-onset autosomal dominant Alzheimer disease: Previous research has reported that NSAIDs only alter Alzheimer disease incidence in ApoE4 carriers, suggesting an interaction between the potential therapeutic mechanism of NSAIDs and the pathological mechanisms of ApoE4.